Thursday, August 5, 2010
Tenaxis Medical, a developer of sealants that close surgical incisions, has raised $9.6 million of an expected $16.6 million in equity, according to a filing with the SEC. The company’s ArterX Vascular Sealant can achieve hemostasis, or cause bleeding to stop, in 15 seconds after it is applied to a suture line. Tenaxis is currently working on a new sealant for the gastrointestinal tract as well. The company was founded in 2004 and is based in Mountain View, Calif.